Beurs gesloten -
Hong Kong S.E.
10:08:20 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
13,48
HKD
|
+5,81%
|
|
+6,81%
|
-54,46%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
53.985
|
114.126
|
353.422
|
318.544
|
223.341
|
51.944
|
51.944
|
-
|
Bedrijfswaarde
1 |
49.901
|
109.822
|
348.931
|
312.303
|
219.728
|
108.159
|
44.936
|
43.879
|
K/w-verhouding
|
91,7
x
|
116
x
|
216
x
|
97,9
x
|
52,3
x
|
34,9
x
|
13,8
x
|
10,8
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
21,3
x
|
28,6
x
|
63
x
|
31
x
|
14,6
x
|
6,67
x
|
2,84
x
|
2,36
x
|
Bedrijfswaarde/omzet
|
19,7
x
|
27,6
x
|
62,2
x
|
30,4
x
|
14,4
x
|
6,35
x
|
2,46
x
|
1,99
x
|
Bedrijfswaarde/EBITDA
|
46,1
x
|
65,7
x
|
142
x
|
68
x
|
32
x
|
15,5
x
|
7,01
x
|
5,56
x
|
Bedrijfswaarde/FCF
|
-86,2
x
|
-54,8
x
|
-83,5
x
|
-101
x
|
-673
x
|
129
x
|
264
x
|
19,3
x
|
FCF Yield
|
-1,16%
|
-1,82%
|
-1,2%
|
-0,99%
|
-0,15%
|
0,77%
|
0,38%
|
5,19%
|
Price to Book
|
6,75
x
|
8,93
x
|
17,2
x
|
10,3
x
|
6,37
x
|
2,9
x
|
1,17
x
|
1,04
x
|
Aantal aandelen (in duizenden)
|
3.677.824
|
3.883.578
|
4.084.763
|
4.224.123
|
4.225.262
|
4.162.831
|
4.162.831
|
-
|
Referentieprijs
2 |
14,68
|
29,39
|
86,52
|
75,41
|
52,86
|
12,48
|
12,48
|
12,48
|
Datum van publicatie
|
18/03/19
|
26/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
26/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
2.534
|
3.984
|
5.612
|
10.290
|
15.269
|
17.034
|
18.280
|
22.036
|
EBITDA
1 |
1.083
|
1.671
|
2.464
|
4.590
|
6.857
|
6.993
|
6.413
|
7.892
|
Bedrijfsresultaat (EBIT)
1 |
871
|
1.156
|
2.008
|
3.327
|
4.609
|
4.253
|
4.904
|
6.125
|
Operationele Marge
|
34,36%
|
29,02%
|
35,79%
|
32,33%
|
30,18%
|
24,97%
|
26,83%
|
27,79%
|
Resultaat voor belastingen (EBT)
1 |
737,7
|
1.127
|
1.966
|
3.993
|
5.358
|
4.174
|
4.749
|
6.023
|
Nettowinst (verlies)
1 |
630,5
|
1.010
|
1.689
|
3.388
|
4.420
|
3.400
|
3.919
|
4.987
|
Nettomarge
|
24,88%
|
25,36%
|
30,09%
|
32,93%
|
28,95%
|
19,96%
|
21,44%
|
22,63%
|
WPA
2 |
0,1600
|
0,2533
|
0,4000
|
0,7700
|
1,010
|
0,7700
|
0,9044
|
1,154
|
Free Cash Flow
1 |
-579
|
-2.003
|
-4.178
|
-3.106
|
-326,7
|
373,9
|
170,5
|
2.276
|
FCF-marge
|
-22,84%
|
-50,27%
|
-74,44%
|
-30,19%
|
-2,14%
|
2,22%
|
0,93%
|
10,33%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
6,3%
|
2,66%
|
28,83%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
9,74%
|
4,35%
|
45,63%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
18/03/19
|
26/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
26/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Omzet
1 |
1.944
|
3.668
|
4.407
|
5.883
|
7.206
|
8.062
|
8.492
|
8.542
|
8.016
|
10.047
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-
|
1.773
|
1.553
|
2.484
|
2.054
|
2.434
|
1.819
|
2.108
|
2.583
|
Operationele Marge
|
-
|
-
|
40,24%
|
26,4%
|
34,47%
|
25,47%
|
28,66%
|
21,29%
|
26,3%
|
25,71%
|
Resultaat voor belastingen (EBT)
1 |
-
|
1.261
|
-
|
-
|
-
|
2.428
|
2.529
|
1.645
|
-
|
-
|
Nettowinst (verlies)
1 |
-
|
952,8
|
-
|
1.546
|
-
|
1.885
|
2.267
|
1.133
|
-
|
-
|
Nettomarge
|
-
|
25,97%
|
-
|
26,28%
|
-
|
23,38%
|
26,69%
|
13,26%
|
-
|
-
|
WPA
|
-
|
-
|
-
|
-
|
-
|
-
|
0,5200
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
21/09/20
|
23/03/21
|
23/08/21
|
22/03/22
|
17/08/22
|
22/03/23
|
23/08/23
|
26/03/24
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
4.084
|
4.304
|
4.491
|
6.241
|
3.612
|
5.448
|
7.008
|
8.065
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-579
|
-2.003
|
-4.178
|
-3.106
|
-327
|
374
|
171
|
2.276
|
ROE (netto-inkomsten/eigen vermogen)
|
10,5%
|
11,6%
|
10,1%
|
12,8%
|
13,1%
|
9,02%
|
9,06%
|
10,4%
|
ROA (netto-inkomsten/totale activa)
|
8,86%
|
8,93%
|
7,25%
|
9,28%
|
9,45%
|
6,41%
|
6,9%
|
8,2%
|
Totale activa
1 |
7.120
|
11.317
|
23.283
|
36.498
|
46.798
|
53.070
|
56.803
|
60.819
|
Nettoactief per aandeel
2 |
2,170
|
3,290
|
5,030
|
7,300
|
8,290
|
9,270
|
10,70
|
12,00
|
Cashflow per aandeel
2 |
0,1900
|
0,3000
|
0,4400
|
0,7700
|
1,270
|
1,410
|
1,580
|
1,760
|
Capex
1 |
1.341
|
3.211
|
6.025
|
6.508
|
5.868
|
5.552
|
5.306
|
4.589
|
Capex/omzet
|
52,89%
|
80,59%
|
107,35%
|
63,24%
|
38,43%
|
32,97%
|
29,03%
|
20,82%
|
Datum van publicatie
|
18/03/19
|
26/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
26/03/24
|
-
|
-
|
Laatste slotkoers
12,48
CNY Gemiddelde koersdoel
26,4
CNY Spread / Gemiddelde doel +111,57% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -54,46% | 7,17 mld. | | -2,31% | 103 mld. | | +0,56% | 95,28 mld. | | +1,69% | 22,15 mld. | | -17,37% | 21,02 mld. | | -9,30% | 18,15 mld. | | -41,01% | 16,74 mld. | | -14,85% | 16,05 mld. | | +3,21% | 13,68 mld. | | +33,54% | 12,17 mld. |
Biotherapeutische geneesmiddelen
|